|
End-of-day quote
Shenzhen S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 33.27 CNY | +2.06% |
|
+0.21% | -0.83% |
| 09-04 | ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China | MT |
| 09-04 | ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial | MT |
| Market Cap | 14.92B 2.23B 1.98B 1.85B 1.68B 3.17B 214B 3.2B 22.34B 8.66B 109B 8.36B 8.17B 351B | P/E 2026 * |
28.7x | P/E 2027 * | -145x |
|---|---|---|---|---|---|
| Enterprise Value | 14.92B 2.23B 1.98B 1.85B 1.68B 3.17B 214B 3.2B 22.34B 8.66B 109B 8.36B 8.17B 351B | EV / Sales 2026 * |
13.8x | EV / Sales 2027 * | 11.9x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.06% | ||
| 1 week | +0.21% | ||
| 1 month | -9.84% | ||
| 3 months | -16.15% | ||
| 6 months | -11.04% | ||
| Current year | -0.83% |
| 1 week | 32.2 |  | 33.8 |
| 1 month | 32.2 | | 38.8 |
| Current year | 29.31 | | 45.88 |
| 1 year | 29.31 | | 62.5 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 2015-11-10 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 2015-11-10 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 2020-12-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 2015-11-10 |
Han Dong Li
BRD | Director/Board Member | 58 | 2015-11-10 |
Liang Wen Huang
CHM | Chairman | 50 | 2015-11-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/5/26 | Buy | Director | 4,200 | 0.0010% | ||
| 11/24/25 | Buy | Director | 7,000 | 0.0017% | ||
| 9/1/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.06% | +0.21% | -44.02% | +29.76% | 2.23B | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.01% | -3.37% | +20.05% | +54.41% | 369.94B | |
| Weighted average by Cap. | +0.42% | -3.33% | +30.47% | +68.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 161M 143M 134M 122M 230M 15.48B 232M 1.62B 626M 7.92B 605M 592M 25.41B | 1.26B 188M 167M 156M 142M 267M 18.04B 270M 1.88B 730M 9.22B 704M 689M 29.59B |
| Net income | 526M 78.45M 69.7M 65.06M 59.3M 112M 7.54B 113M 787M 305M 3.86B 295M 288M 12.37B | -102M -15.21M -13.52M -12.62M -11.5M -21.69M -1.46B -21.89M -153M -59.16M -748M -57.12M -55.88M -2.4B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥33.27 | +2.06% | 4,399,720 |
| 26-09-29 | CN¥32.60 | +0.31% | 2,890,200 |
| 26-09-28 | CN¥32.50 | -2.11% | 3,291,202 |
| 26-09-24 | CN¥33.20 | -3.40% | 5,514,326 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
